Probable Reversible Encephalopathy with Ceftazidime/Avibactam and Aztreonam: A Case Report. (2026). Asian Journal of Pharmaceutical and Health Sciences, 16(2), 3283-3287. https://doi.org/10.5530/ajphs.2026.16.94